Nuvectis Pharma Inc (NVCT) — Tangible Net Worth Ratio
Nuvectis Pharma Inc (NVCT) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($24.01 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Nuvectis Pharma Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Nuvectis Pharma Inc Tangible Net Worth Ratio (2020–2024)
This chart shows how Nuvectis Pharma Inc's Tangible Net Worth Ratio has changed across 4 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $24.01 Million with intangible assets of $0.00 USD. Also explore Nuvectis Pharma Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Nuvectis Pharma Inc (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Nuvectis Pharma Inc from 2020 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Nuvectis Pharma Inc (NVCT) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $9.71 Million | $0.00 | $18.61 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $12.20 Million | $0.00 | $19.18 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $14.22 Million | $0.00 | $20.41 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $6.65 Million | $0.00 | $6.66 Million | — |